Why David Einhorn’s Greenlight prefers this tiny biotech over AI ‘excitement’

by | Oct 22, 2025 | Uncategorized

Spread the love
Greenlight Capital’s third-quarter investor letter had almost nothing good to say about the hot AI trend, but it does have faith in a tiny biotech.

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments